Clover Corporation CLV.AX · AUD

Its shares trade on ASX under the ticker CLV.AX. It has been listed since 30 November 1999. In the fiscal year to 31 July 2026, it reported revenue of A$97.4m and net income of A$10.5m. At that date it held total assets of A$97.8m and shareholders' equity of A$78.0m.

Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. The company is headquartered in Melbourne, Victoria. The firm is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. The company focuses on developing nutrients for use in foods or as nutritional supplements. The firm provides lipid-based ingredients for the food industry. The company focuses on the delivery of bioactive ingredients using encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. The firm offers an encapsulated oil and a food grade high docosahexaenoic acid (DHA) oil. The company has a technology license for the encapsulation of marine and algal oils. The firm has a manufacturing plant for tuna oils and related products in Altona, Victoria. Its geographical segments include Australia/New Zealand, Asia, Europe and America.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Rupert HarringtonNon-Executive Chairman of the BoardA$130,511
• Mr. Peter DaveyChief Executive Officer, Managing Director, Executive Director, since 2014A$663,653
• Mr. Andrew AllibonChief Financial Officer, Company SecretaryA$295,243
• Mr. Graeme BillingsIndependent Non-Executive DirectorA$79,194
• Ms. Toni BrendishNon-Executive Independent DirectorA$73,936
• Mr. Ian GlassonNon-Executive Independent DirectorA$79,194
• Dr. Simon GreenNon-Executive Independent DirectorA$73,936

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.